Abstract: Streptococcus pneumoniae (SP) is a common human pathogen associated with a broad 14 spectrum of diseases and it is still a leading cause of mortality and morbidity worldwide, especially 
Introduction

31
Streptococcus pneumoniae (SP) represents a relevant cause of infections associated with high 32 mortality and morbidity: invasive pneumococcal disease (IPD) indeed still shows a high incidence virulence among population in a process defined "serotype replacement". 7 Indeed, most of the 12 PCV7 recipients achieved a significant concentration of antibodies for the vaccine-associated 13 serotype, but the absence of 19A opsonophagocytic activity indicates that such antibodies are not-14 functional against 19A. 8 The immunogenicity of the19F vaccine serotype, and the level of cross-15 opsonophagocytic antibodies can be influenced by the conjugation method used to connect the 16 antigenic saccharide fragment to the T-helper peptide, like reductive amination vs cyanylation. 9 The 17 lack of antibody-related cross-protection between serotypes 19F and 19A may be alternatively 18 related to conformational differences between the two CPS structures. 10 Of note, the problem to between the three monosaccharides which make up the final trisaccharide. In particular, 39 trisaccharide 1 was assembled with higher yields when the -Glc-(13)-Rha disaccharide was 1 glycosylated with a glucose moiety, followed by epimerization at C2.
2
Finally, we evaluated the binding affinity of trisaccharide 1 towards anti-19A and anti-19F sera, to 3 investigate the role of the carbohydrate portion of the repeating unit in the antibody binding affinity.
4
Trisaccharide 1 showed a similar and moderate activity towards both sera, indicating that a limited 5 cross recognition exists at the level of the single repeating unit. 
Results and discussion
10
Chemistry
11
A key point in our synthetic strategy towards compound 1 has been the preparation of protected promoted using silver triflate-N-iodosuccinimide system as previously described, 19 and gave 
Biology
7
The ability of increasing concentrations (from 10 -7 -10 0 mg/mL) of the newly synthetized 
15
As expected the natural polysaccharide exhibited higher efficacy (100% inhibition at 10 -1 mg/mL) 16 and affinity (EC 50 = 9.1x10 -5 mg/mL) than synthetized compound (41% inhibition at 10 0 mg/mL 17 and EC 50 =1.3 x 10 -3 ) confirming that saccharide chain length seems to be important for their were evaluated by a competitive ELISA method.
9 10
Conclusions
11
In conclusion, the synthesis of compound 1, an aminopropyl derivative of the trisaccharide 12 repeating unit of SP 19A, has been developed exploiting rhamnosyl acceptor 3, already 13 functionalized with an aminopropyl linker. We developed a new and more efficient synthetic route 14 to the rhamnosyl acceptor, which allows to obtain compound 3 in 40% overall yield over four steps.
15
Two different synthetic strategies were used to build trisaccharide 1, allowing a direct comparison Finnigan LCQ™DECA ion trap mass spectrometer; equipped with a Finnigan ESI interface.
11
High-resolution mass spectra were collected by electrospray ionization (ESI) spectroscopy on a
12
QTof SYNAPT G2Si Mass Spectrometer. NaH was washed with hexane three times prior to 13 use.
14 15 (2 x 100 mL). The combined organic layers were dried over Na 2 SO 4 and concentrated. Purification 
4.1.1.Synthesis of N-(benzyloxycarbonyl)aminopropyl 2,3,4-tri-O-acetyl--L-rhamnopyranoside (5)
Synthesis of N-benzyl-N-benzyloxycarbonyl-3-aminopropyl 2,4-di-O-benzyl-3-O-trityl--L-
A mixture of 6 (1.60 g, 4.50 mmol), trityl chloride (2.51 g, 9.00 mmol) and dry pyridine (15 mL) 3 was stirred at 60 °C for 20 h. After the addition of Et 3 N (2 mL), the reaction was diluted with 4 EtOAc (50 mL) and washed with HCl 1N (2 x 50 mL). The combined aqueous phases were 5 extracted with AcOEt (3 x 40 mL), and then the combined organics were washed with satd. 
Synthesis of N-benzyl-N-benzyloxycarbonyl-3-aminopropyl 2,4-di-O-benzyl--L-
Synthesis of N-benzyl-N-benzyloxycarbonyl-3-aminopropyl 2,3-di-O-benzyl-4,6-O-
42
benzylidene--D-glucopyranosyl-(13)-2,4-di-O-benzyl--L-rhamnopyranoside (9)
Synthesis of N-benzyl-N-benzyloxycarbonyl-3-aminopropyl 2,3,6-tri-O-benzyl--D-
10
glucopyranosyl-(13)-2,4-di-O-benzyl--L-rhamnopyranoside (10)
11
Compound 9 (0.45 g, 0.43 mmol) and 4 Å m.s. (0.45 g) were dissolved in DCM (10 mL), stirred at 12 room temperature for 15 minutes, then the suspension was cooled at 0 °C. Triethylsilane (0.63 mL, 4.30 mmol) was added, followed by the slow dropwise addition of BF 3 .Et 2 O (0.27 mL, 2.15 mmol). 
Synthesis of N-benzyl-N-benzyloxycarbonyl-3-aminopropyl 2-O-acetyl-3-O-benzyl-4,6-O-
28
benzylidene--D-glucopyranosyl-(14)-2,3,6-tri-O-benzyl--D-glucopyranosyl-(13)-2,4-di-O-
Synthesis of N-benzyl-N-benzyloxycarbonyl-3-aminopropyl 3-O-benzyl-4,6-O-benzylidene--
D-glucopyranosyl-(14)-2,3,6-tri-O-benzyl--D-glucopyranosyl-(13)-2,4-di-O-benzyl--L-
Synthesis of N-benzyl-N-benzyloxycarbonyl-3-aminopropyl 3-O-benzyl-4,6-O-benzylidene-2-
23
O-(N-imidazole-1-sulfonyl)--D-glucopyranosyl-(14)-2,3,6-tri-O-benzyl--D-glucopyranosyl-
(13)-2,4-di-O-benzyl--L-rhamnopyranoside (14)
25 NaH (60 % in oil, 0.070 g, 1.76 mmol) was added to a stirred solution of compound 13 (0.23 g, 0.16 26 mmol) in dry DMF (3.5 mL) at room temperature. After 1 h, the suspension was cooled at -40 °C 
Synthesis of N-benzyl-N-benzyloxycarbonyl-3-aminopropyl 2-azido-3-O-benzyl-4,6-O-
48
benzylidene-2-deoxy--D-mannopyranosyl-(14)-2,3,6-tri-O-benzyl--D-glucopyranosyl-(13)-
49
2,4-di-O-benzyl--L-rhamnopyranoside (15)
To a stirred solution of 14 (0.20 g, 0.13 mmol) in dry DMF (4 mL), sodium azide (0.085g, 1.30 1 mmol) was added and the resulting solution was heated at 80 °C. After 5 h, the reaction was cooled 
Synthesis of phenyl 2-O-acetyl-3-O-benzyl-4,6-O-benzylidene--D-glucopyranosyl-(14)-
21
2,3,6-tri-O-benzyl-1-thio--D-glucopyranoside (18)
Synthesis of 3-aminopropyl 2-acetamido-2-deoxy--D-mannopyranosyl-(14)--D-
47
glucopyranosyl-(13)--L-rhamnopyranoside hydrochloride salt (1)
48
Compound 2 (0.080 g, 0.056 mmol) in AcOEt/MeOH/0.02M HCl, 1:1:1 (9 mL) was 49 hydrogenolyzed over Pd(OH) 2 (0.070 g) for 4 days. The mixture was filtered over pleated filter
